Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion

• Status: Completed
• Trial end date: 2020-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

investigators aim through this study to evaluate and compare the Safety and efficacy of different doses of misoprostol prior to IUCD insertion among women with nulliparous cervix beside the rate of occurrence of adverse effects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Contraceptive Agents; Misoprostol

Criteria

Inclusion Criteria:

• Non-pregnant,

• Nulliparous cervix: no previous vaginal delivery or any attempt of vaginal delivery,

• Seeking for IUD insertion,

• Signing an informed consent to participate in the study,

Exclusion Criteria:

• Pregnancy or signs of pregnancy,

• Signs of cervicitis,

• Any uterine abnormalities as congenital anomalies, endometrial lesions, adenomyosis, fibroids and intrauterine adhesions,

• Women with any kind of pelvic pain,

• Abnormal uterine bleeding,

• History of cervical surgery,• Vaginal delivery,

• Contraindication to misoprostol as allergy,

• Administration of any analgesics last 12h,

• Withdrawal of consent